Literature DB >> 2396886

Skeletal muscle ventricles for total heart replacement.

A Pochettino1, A D Spanta, R L Hammond, D R Anderson, C R Bridges, P Samet, H Niinami, E Hohenhaus, S Salmons, L W Stephenson.   

Abstract

Skeletal muscle ventricles (SMV) were constructed from canine left latissimus dorsi muscle. The animals were divided into three groups: group A (n = 5), SMVs rested 4 weeks without electrical conditioning; group B (n = 6), SMVs rested 4 weeks and then electrically conditioned for 6 weeks; group C (n = 5), SMVs rested 18 weeks without electrical conditioning. At the end of each protocol, the SMVs were acutely tested by connecting them to a mock-circulation device. The SMVs in group C developed stroke work at physiologic preloads superior to any previously reported, as high as 194% of left ventricular stroke work at afterloads of 80 mmHg. The SMVs in group B developed work outputs equivalent to 53% of the left ventricle, which is still more than four times that of the right ventricle. The results show that it is possible to harvest sufficient work from skeletal muscle ventricles to fully replace cardiac function at physiologic preloads.

Entities:  

Mesh:

Year:  1990        PMID: 2396886      PMCID: PMC1358170          DOI: 10.1097/00000658-199009000-00013

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  29 in total

1.  Interactions between motoneurones and muscles in respect of the characteristic speeds of their responses.

Authors:  A J BULLER; J C ECCLES; R M ECCLES
Journal:  J Physiol       Date:  1960-02       Impact factor: 5.182

2.  Combined registry for the clinical use of mechanical ventricular assist pumps and the total artificial heart: third official report--1988.

Authors:  W E Pae; C A Miller; W S Pierce
Journal:  J Heart Transplant       Date:  1989 Jul-Aug

3.  The Registry of the International Society for Heart Transplantation: sixth official report--1989.

Authors:  C F Heck; S J Shumway; M P Kaye
Journal:  J Heart Transplant       Date:  1989 Jul-Aug

4.  Changes in the size and synthetic activity of nuclear populations in chronically stimulated rabbit skeletal muscle.

Authors:  R E Joplin; L L Franchi; S Salmons
Journal:  J Anat       Date:  1987-12       Impact factor: 2.610

5.  The muscle-powered dual-chamber counterpulsator: rheologically superior implantable cardiac assist device.

Authors:  G Kochamba; C Desrosiers; M Dewar; R C Chiu
Journal:  Ann Thorac Surg       Date:  1988-06       Impact factor: 4.330

6.  Implantable extra-aortic balloon assist powered by transformed fatigue-resistant skeletal muscle.

Authors:  R C Chiu; G L Walsh; M L Dewar; J H De Simon; A S Khalafalla; D Ianuzzo
Journal:  J Thorac Cardiovasc Surg       Date:  1987-11       Impact factor: 5.209

7.  Power output of skeletal muscle ventricles in circulation: short-term studies.

Authors:  J D Mannion; M A Acker; R L Hammond; W Faltemeyer; S Duckett; L W Stephenson
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

8.  Dynamic cardiomyoplasty: a new approach to assist chronic myocardial failure.

Authors:  J C Chachques; P A Grandjean; J J Tommasi; P Perier; S Chauvaud; I Bourgeois; A Carpentier
Journal:  Life Support Syst       Date:  1987 Oct-Dec

9.  Dynamic aortomyoplasty to assist left ventricular failure.

Authors:  J C Chachques; P A Grandjean; E I Cabrera Fischer; C Latremouille; V A Jebara; I Bourgeois; A Carpentier
Journal:  Ann Thorac Surg       Date:  1990-02       Impact factor: 4.330

10.  Skeletal muscle ventricles: improved performance at physiologic preloads.

Authors:  C R Bridges; W E Brown; R L Hammond; D R Anderson; W A Anderson; F Dimeo; L W Stephenson
Journal:  Surgery       Date:  1989-08       Impact factor: 3.982

View more
  2 in total

1.  Using skeletal muscle to assist the heart.

Authors:  T L Hooper; L W Stephenson
Journal:  Br Heart J       Date:  1991-10

2.  Autobionics: a new paradigm in regenerative medicine and surgery.

Authors:  Hutan Ashrafian; Ara Darzi; Thanos Athanasiou
Journal:  Regen Med       Date:  2010-03       Impact factor: 3.806

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.